Biotech firm Gilead Sciences has announced plans to voluntarily withdraw the US accelerated approval for Trodelvy ...

India's biotechnology sector is witnessing remarkable growth, with the country's bioeconomy now valued at USD 150 billion but there is still significant untapped potential in innovation and product ...

As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Industry Research Assistance Council ...

The funds will be used to accelerate its mooMark business, which focuses on contract manufacturing and private-label dairy ...